X0206 3 2020-09-24 0 0001699382 PMV Pharmaceuticals, Inc. PMVP 0001207833 ORONSKY ARNOLD L C/O PMV PHARMACEUTICALS, INC. 8 CLARKE DRIVE, SUITE 3 CRANBURY NJ 08512 1 0 1 0 Series Seed Preferred Stock 0.00 Common Stock 1620101 I See footnote Series A Preferred Stock 0.00 Common Stock 3488398 I See footnote Series B Preferred Stock 0.00 Common Stock 1040654 I See footnote Series C Preferred Stock 0.00 Common Stock 265203 I See footnote The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. The shares are directly held by InterWest Partners X, LP ("InterWest X"). InterWest Management Partners X, LLC ("IMP X"), as the general partner of InterWest X, may be deemed to beneficially own the shares held by InterWest X. The Reporting Person is a managing director of IMP X, and as such may be deemed to beneficially own the shares held by InterWest X. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein. /s/ Karen Wilson, Attorney-in-Fact for Arnold L. Oronsky 2020-09-24